Still open for a spontaneous visit 👇🏻

🔍 Spondiloartriti Assiali: L'Importanza della Diagnosi Precoce🔍 Le spondiloartriti assiali rappresentano una sfida diagnostica, ma riconoscerle in tempo può fare una grande differenza nella gestione della malattia e nella qualità della vita dei pazienti pharmastar.it/pharmastartv//…

Our latest study on RA patients treated with JAK inhibitors reveals a 📈 Herpes Zoster incidence of 2.95 per 100 patient-years. Key predictors: disease duration ⏳, time on JAKi ⌛, and higher disease activity 🔥 mdpi.com/2889928 #mdpijcm via JCM MDPI

📢 Special Issue Alert! 🧬 Exploring Axial Spondyloarthritis (axSpA) & Psoriatic Arthritis (PsA): 🔬 Pathogenetic Mechanisms 🖼️ Advanced Imaging 💊 Innovative Treatments Submit your research! 🌟 mdpi.com/si/212993 #mdpiijms via IJMS MDPI

🚀 Thrilled to share a new work with my friends Vincenzo Venerito & Dr. Fabian Proft ! 🎉 We explore the evolution of #axSpA treatment, from early intervention with biologics and synthetic drugs to personalized strategies for optimal outcomes. 🩺🔬 tandfonline.com/doi/full/10.10…

😍 Excited to participate in the GRAPPA Workshop 2024 in Cagliari! 🌊🌞 I’ll be presenting on “What have we learned from anti-JAK therapy in Psoriatic disease?”🧬💊 A great chance to share insights on PsA and engage with experts. 🤝💡 Thanks to the organizers! 🙏 GRAPPA Network - Official

🌟 Exciting insights shared today at the GRAPPA Workshop 2024 in beautiful Cagliari! 🇮🇹 Presented data on the efficacy of JAK inhibitors in Psoriatic Arthritis (PsA) 💊, showing significant improvements in VAS pain, PtGA, and PhGA over time 📊 GRAPPA Network - Official

🧠 New study alert! In collaboration with Prof. Maria Sole Chimenti we explored the prevalence & characteristics of neuropathic pain in #Spondyloarthritis, including axSpA, PsA, & peripheral SpA. 💥 Andrea Cito Maria Sole Chimenti #Rheumatology #ChronicPain #SpA #Research

Excited for the upcoming #SIRPuglia 🎉 where we'll discuss real-world data on #Ixekizumab 💉 in #PsoriaticArthritis (PsA) 🔥! Looking forward to exploring its impact on patient outcomes 🙌 and treatment strategies 🧠✨. Let’s advance #Rheumatology together! Lilly Italia

From the current issue: A cross-sectional study showing neuropathic pain was prevalent in patients with #spondyloarthritis by Giuseppe Lopalco sciencedirect.com/science/articl…

Neuropathic pain is common among patients with spondyloarthritis (SpA), highlighting the need for accurate diagnosis and personalized therapeutic strategies. PharmaStar Seminars in Arthritis and Rheumatism Maria Sole Andrea Cito Read more: pharmastar.it/news/dolore/do…

Malattia di Behçet, un nuovo studio valuta le terapie più efficaci osservatoriomalattierare.it/malattie-rare/…

🔄RT: gerard espinosa Luca Cantarini Giuseppe Lopalco George Bertsias Laurent ARNAUD Alessia Alunno INTERNATIONAL SOCIETY FOR BEHÇET’S DISEASE ABDA Behçet's UK

🌟 Explore the Complexities of Psoriatic Arthritis! 🌟 📚 This course will focus on: 🔍 Pathogenesis, diagnosis, and management 🩺 Evolving clinical manifestations 📸 The role of imaging and differential diagnosis 🤝 Interdisciplinary collaboration Vincenzo Venerito

🎯 Targeting refractory Behçet’s disease: a new therapeutic perspective ✨ Proud to share our latest publication in Internal and Emergency Medicine showcasing the potential of upadacitinib (JAK-1 inhibitor) in managing a challenging case of refractory Behçet’s disease.

🔬✨ New GISEA Registry Study on Secukinumab in 1045 Psoriatic Arthritis (PsA) Patients ✨🔬 Evaluating effectiveness & treatment persistence across all PsA domains! 📊🩺 pharmastar.it/sharepage.html…

📢 New study on Secukinumab in PsA! 🏥 from GISEA 🔹 63.2% drug survival at 24 months 🔹 Improved disease activity (DAPSA, PASI, ASDAS-CRP) 📉 🔹 Higher persistence in mixed PsA (peripheral+axial) 🔹 Well-tolerated, no serious AEs! 💊✅ Sage Journals 🔗 doi.org/10.1177/175972…

ASAS Definition of Difficult-to-Manage including Treatment Refractory Axial Spondyloarthritis is published now! Read the article here: sciencedirect.com/science/articl… or listen to the latest episode of RheumaCast open.spotify.com/show/2LzByQKC1…

🧬 Just published! Our new work with Prof. Denis Poddubnyy, Torsten Diekhoff, Andrea Cito and Dr. Fabian Proft 🦴 We explore the interplay between 🕳️ bone erosion and 🧱 new bone formation in axSpA and PsA Frontiers - Immunology 📚 Read the full article: frontiersin.org/journals/immun…

🚨 Just Published in Sᴡɪss Uʟᴛʀᴀsᴏᴜɴᴅ Cᴇɴᴛᴇʀ - UZR🚨 📢 We’re proud to present the largest real-world study to date on psoriatic arthritis (PsA) patients treated with upadacitinib (UPA) academic.oup.com/rheumatology/a…